These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9399851)
1. Software and database for the analysis of mutations in the human WT1 gene. Jeanpierre C; Béroud C; Niaudet P; Junien C Nucleic Acids Res; 1998 Jan; 26(1):271-4. PubMed ID: 9399851 [TBL] [Abstract][Full Text] [Related]
2. Genotype/phenotype correlations in Wilms' tumor. Huff V Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067 [TBL] [Abstract][Full Text] [Related]
3. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
4. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284 [TBL] [Abstract][Full Text] [Related]
5. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364 [TBL] [Abstract][Full Text] [Related]
6. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients. Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260 [TBL] [Abstract][Full Text] [Related]
7. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368 [TBL] [Abstract][Full Text] [Related]
8. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Klamt B; Koziell A; Poulat F; Wieacker P; Scambler P; Berta P; Gessler M Hum Mol Genet; 1998 Apr; 7(4):709-14. PubMed ID: 9499425 [TBL] [Abstract][Full Text] [Related]
9. The role of Wilms' tumor genes. Hirose M J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307 [TBL] [Abstract][Full Text] [Related]
10. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614 [TBL] [Abstract][Full Text] [Related]
11. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852 [TBL] [Abstract][Full Text] [Related]
12. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X. Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209 [TBL] [Abstract][Full Text] [Related]
13. Constitutional WT1 mutations in Wilms' tumor patients. Diller L; Ghahremani M; Morgan J; Grundy P; Reeves C; Breslow N; Green D; Neuberg D; Pelletier J; Li FP J Clin Oncol; 1998 Nov; 16(11):3634-40. PubMed ID: 9817285 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189 [TBL] [Abstract][Full Text] [Related]
15. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients. Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1. Matsuzawa-Watanabe Y; Inoue J; Semba K Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737 [TBL] [Abstract][Full Text] [Related]
17. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor]. Jiang YP; Shen Y; Sun N; Wang H Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811 [TBL] [Abstract][Full Text] [Related]
18. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497 [TBL] [Abstract][Full Text] [Related]
19. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations. Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587 [TBL] [Abstract][Full Text] [Related]
20. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation. Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]